A phaseIIstudy of anlotinib in 45 patients with relapsed small cell lung cancer

Wu, D; Nie, J; Hu, WH; Dai, L; Zhang, J; Chen, XL; Ma, XJ; Tian, GM; Han, JD; Han, S; Long, JR; Wang, Y; Zhang, ZR; Fang, J

Fang, J (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Thorac Oncol 2,Minist Educ Beijing, Beijing, Peoples R China.

INTERNATIONAL JOURNAL OF CANCER, 2020; 147 (12): 3453

Abstract

The purpose of this prospective phase II clinical trial was to investigate the efficacy and safety of anlotinib in patients with relapsed small cell l......

Full Text Link